About IDDI
We are an expert clinical data services and high-level strategic consulting contract research organization (CRO), providing agile clinical trials services for pharmaceutical, biotech, and medical device/diagnostic companies.
With a proven track record, IDDI provides expert Biostatistics and eClinical Services to ensure the successful execution of your clinical development program.
Passion. Science. Experience.
A passionate and experienced science-led team, committed to delivering submission-ready clinical data.
Meet Our TeamCommitment to Quality and Precision
“IDDI was of great benefit, particularly with respect to their responsiveness, their commitment to quality and precision, and their ability to meet our very ambitious timelines.”
Jim Taylor, CEO Oraya Therapeutics, Newark, CA, USA

How IDDI Adds Value to Your Clinical Data
Strategic-level consultancy to optimize your clinical development program even in clinical trials with complex settings.
Delivered by talented, forward-thinking and science-led professionals, who will take ownership of your needs.
Over 30 years in business ensuring continuity in your clinical development.
IDDI’s culture is scientifically driven, thanks to its founder and Chief Scientific Officer, Marc Buyse, ScD.
Expert clinical data services (EDC/RTSM/Medical Coding) providing flexible solutions for collection, standardization, analysis, documentation and reporting of your clinical data.
A Project Manager is assigned to every project. Flexibility, responsiveness, proactiveness are skills often mentioned by our customers.
Experienced contract research organization with a solid understanding of the clinical development process and breadth of therapeutic areas expertise.
Thanks to a strong collaborative approach with Academics and Key Opinion Leaders.
Resource Library
Discover our on-demand recorded webinars, podcasts, videos and scientific articles.
Fast growing company – Rewarding career. Join us and contribute to the progress of clinical research. An inspiring and exciting career with international and challenging projects is waiting for you!
Join UsMarch 30, 2023
Supporting Shared Decision-making and Communication in Breast Cancer: The ShareView Project
Join IDDI webinar to learn more about the ShareView Project which investigated communication approaches and shared decision-making practices across Europe…
View WebinarRe-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in HER2–Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti–HER2 Therapy
Abstract: Purpose Pathologic complete response (pCR) has prognostic importance and is frequently used as a primary end point, but doubts…
Supporting Shared Decision-making and Communication in Breast Cancer: The ShareView Project
Join IDDI webinar to learn more about the ShareView Project which investigated communication approaches and shared decision-making practices across Europe…
Meeting randomization & clinical supply challenges head-on
Strategic partnership to pair long-standing clinical research expertise with a best-in-class RTSM system
IDDI at OCT Southeast 2023
Meet IDDI’s experts at the Outsourcing in Clinical Trials Southeast 2023 on 28 and 29 March in Raleigh-Durham, NC –…
IDDI at Clinical Research Day 2023 by AFCROs
Meet IDDI at the 11th Clinical Research Day by AFCROs in Paris! Come visit us at Booth #15! Schedule a…
IDDI at OCT West Coast 2023
Meet IDDI at the Outsourcing in Clinical Trials West Coast 2023! Schedule a meeting with Shruti Jituri, IDDI’s Director Business…
IDDI at COG UK 2023
Meet IDDI’s experts at the Clinical Outsourcing Group (COG) UK on 21st and 22nd February in London, UK – Visit…
IDDI speaking at National Academies of Sciences, Engineering, and Medicine’s Workshop
Join IDDI at the virtual workshop organized by the National Academies of Sciences, Engineering and Medicine from 30-31 January 2023…
IDDI Newsletter – January 2023
NEWS & EVENTS IDDI APPOINTS LINDA DANIELSON AS ITS NEW CHIEF EXECUTIVE OFFICER IDDI announces the appointment of Linda Danielson…
Adapting the Randomization Algorithm
Discover how IDDI biostatistics-driven RTSM helped the Sponsor to avoid serious imbalance between the two randomized arms for the treated…